Lv1
26 积分 2026-09-03 加入
Safety of ozanimod and etrasimod in ulcerative colitis: A disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System database
1天前
待确认
Effects of Selective Sphingosine-1-Phosphate Receptor 1 Agonist, TRV045, on Evoked Pain Tests: An Exploratory, Four-Way Cross-Over Study in Healthy Volunteers
1天前
已完结
Long-term safety and efficacy of ponesimod, an oral S1P1 receptor modulator, in relapsing-remitting multiple sclerosis (RRMS): Results from randomized phase 2b core and extension studies spanning up to 13 years
1天前
已关闭
Safety of ozanimod and etrasimod in ulcerative colitis: A disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System database
1天前
已关闭
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study
1天前
已完结
Comprehensive Analysis of Ozanimod-Related Adverse Events Based on the FAERS Database
1天前
已完结
Efficacy and Safety of Ozanimod in Ulcerative Colitis: A Real-World Pan-Hellenic Study
1天前
已完结
GLP-1R activation alleviated sepsis-induced cardiac dysfunction by modulating macrophage polarization via the STING/ P65 pathway
1个月前
已关闭
Multi-omics analysis reveals STING activation mediates NLRP3-related pyroptosis and exacerbates myocardial ischemia-reperfusion injury
1个月前
已完结
皖公网安备34019202002308
